Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Colorectal Cancer Metastatic: early-phase trial registry
10 of 19 indexed Colorectal Cancer Metastatic trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 10 currently recruiting · #902 of 28,707 conditions by registered trial count
Colorectal Cancer Metastatic: 19 US clinical trials tracked, 10 recruiting.
Colorectal Cancer Metastatic is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 13 in Phase 1-2 (earlier-stage). The most active sponsor is Northwell Health, running 2 of these trials.
Enrollment posture brief
Registry condition colorectal-cancer-metastatic
OPEN 10 | RECR 53% | LATE 0 | EARLY 13 | RANK #902 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Knee Pain Chronic (53% recruiting · 19 trials)
Colorectal Cancer Metastatic lists 10 open slots (53% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Colorectal Cancer Metastatic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Colorectal Cancer Metastatic is recruiting above its size-band peers.
10 of 19 indexed trials (52.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Colorectal Cancer Metastatic trials is spread across many organizations.
Northwell Health accounts for 2 of 19 trials (10.5%). 17 distinct sponsors appear on at least one study for this condition label.
-
Most Colorectal Cancer Metastatic trials plan to enrol fewer than 100 people.
Median target enrolment is 53 among the 19 trials that report a genuine target (sentinel values excluded). 16 of those (84.2%) plan for fewer than 100 participants.
-
Colorectal Cancer Metastatic research is mostly interventional.
14 interventional and 5 observational studies make up this index (73.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
Mainz Biomed
NCT06864338
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Northwestern University
NCT06698146
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Michael J Cavnar, MD
NCT07201519
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
HealthPartners Institute
NCT06605430
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
University of Chicago
NCT05200442
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
University of Rochester
NCT05248581
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Weill Medical College of Cornell University
NCT06300463
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Buzzard Pharmaceuticals
NCT06634875
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
Northwell Health
NCT07193862
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
Northwell Health
NCT07172282
Assessing How Normal Variations in CT Scanning Affects Its Interpretation
Memorial Sloan Kettering Cancer Center
NCT03038568
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
University of Southern California
NCT03657641
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
University of Chicago
NCT04157322
A Phase 1b Study of WU-NK-101 in Combination With Cetuximab
Wugen
NCT05674526
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
Treos Bio Limited
NCT05243862
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
NCT01298570
Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer
The Rogosin Institute
NCT01053013
A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
Massachusetts General Hospital
NCT03144804
TheraSphere® For Treatment of Metastases in Liver
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT04517643
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 8 |
Top Sponsors
Named interventions
Most-linked intervention names on Colorectal Cancer Metastatic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Colorectal Cancer Metastatic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Colorectal Cancer Metastatic page
19 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Colorectal Cancer Metastatic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Northwell Health sponsors the most Colorectal Cancer Metastatic trials on record, review their full trial history before evaluating a specific study. See Northwell Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colorectal Cancer Metastatic condition card totals 19 registered trials; most-linked intervention RENCA macrobeads; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.